Clinical Performance Evaluation of the C2i Test
NCT05860543
·
clinicaltrials.gov ↗
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
C2i genomics was acquired by veracyte
Conditions
Muscle Invasive Bladder Cancer
Interventions
DIAGNOSTIC_TEST:
C2i-WGS-MRD Test
Sponsor
University of Texas Southwestern Medical Center